Form 4: Dyne Therapeutics SVP Richard Scalzo Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Richard Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold 1,468 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On September 11, 2024, Richard William Scalzo, SVP, Head of Finance & Admin. at Dyne Therapeutics, sold 1,468 shares of common stock.
- The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs) granted on December 10, 2021, and December 9, 2022.
- The shares were sold at a weighted average price of $31.89, with individual transactions ranging from $31.59 to $32.15.
- Following the transaction, Scalzo beneficially owns 99,958 shares, including 98,445 unvested RSUs.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares for tax obligations) with no apparent positive or negative implications for the company's outlook.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| December 10, 2021 | Date of restricted stock units granted to the Reporting Person |
| December 9, 2022 | Date of restricted stock units granted to the Reporting Person |
| 09/11/2024 | Date of the stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.